ARCHIVES

FDA Approves Imaging Agent For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Comprehensive Center List Omits Georgetown/Howard, Adds Arizona

June 1, 1990

NCI, DCT Board Cool Toward AMA, ACOS, VA Role In Clinical Trials

March 3, 1989

NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said

June 24, 1994

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

Group Chairs Seek Role Running NCTN

September 12, 2014